article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

At the same time, the average cost of insulin for patients per year almost doubled from $2,864 to $5,705 between 2012 and 2016. Pharmacists have more insight into a patient’s insurance coverage than most providers, so this change could create a lot of value for patients throughout the country.

article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. However, some may be concerned with this genetic information getting reported on insurance or to employers. The answer is a bit complicated!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHC Comments on the Federal Evidence Agenda on Disability Equity

Putting Patients First Blog

Too often the formal notice and comment process does not reach these marginalized communities and federal agencies must actively work to seek their input in non-traditional ways. This process respects their autonomy by involving them in decision-making to the extent that they are able.

article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

Also, The Enbrel Mini cartridge with AutoTouch autoinjector is a reusable autoinjector designed with patients in mind, with a comfortable gray finger grip, an easy-to-press status button, and a needle designed to remain hidden throughout the injection process Weaknesses: High Cost: Enbrel is an expensive medication, which can limit access for patients (..)

article thumbnail

NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies

Putting Patients First Blog

As these technologies become increasingly integral to patient care, it is essential for CMS to develop clear and consistent guidelines for the payment and coverage of AI-enabled services. Providing clear guidance, technical assistance, and streamlined processes can help facilitate the adoption of this innovative care model.